Clinical Trial Update: EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS) [Phase 3]

View source ↗

Summary

Phase 3 trial in obese women with polycystic ovary syndrome evaluating EQW, DAPA, EQW/DAPA, DAPA/MET ER, and PHEN/TPM ER; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Polycystic Ovary Syndrome

Snippet

Sponsor: Woman's | Conditions: Polycystic Ovary Syndrome, Obesity | Phase 3 | Status: COMPLETED | Results posted: 2021-01-29